Jerry Liu

About

Jerry Liu is a clinician-researcher whose work sits at the critical intersection of head and neck surgical oncology and the evolving landscape of human papillomavirus (HPV)-related oropharyngeal cancer. His primary research focuses on refining treatment paradigms for HPV-positive oropharyngeal squamous cell carcinoma (OPSCC), particularly through the lens of transoral robotic surgery (TORS). Liu’s major contributions include challenging conventional wisdom regarding the management of early-stage disease. His highly cited 2021 study, “Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era” (14 citations), provides crucial data on the pathologic incidence of contralateral nodal spread, directly informing the extent of surgical and radiation fields. Complementing this, his 2020 work on long-term outcomes after TORS failure (10 citations) offers one of the first detailed characterizations of disease progression in recurrent HPV-positive OPC, a poorly understood clinical scenario. Beyond oncology, Liu’s earlier research on computational models, including a 2010 paper on a noise-tolerant Protein Processor Associative Memory (10 citations), demonstrates a unique interdisciplinary breadth. With a growing citation footprint, Jerry Liu is establishing himself as a key voice in de-escalation and personalization of treatment for HPV-driven head and neck cancers.

Research Focus

Key Achievements

Top Papers

1. 1
   Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era

   14 citations · 2021
2. 2
   Long‐term outcomes in patients with recurrent human papillomavirus‐positive oropharyngeal cancer after upfront transoral robotic surgery

   10 citations · 2020
3. 3
   From Bidirectional Associative Memory to a noise-tolerant, robust Protein Processor Associative Memory

   10 citations · 2010

Key Collaborators

Contact & Links